To The Moon

CALL ME CRAZY BUT IN MY VIEW $Meta Platforms, Inc.(META)$ FAIR VALUE IS 2X THE CURRENT PRICE 😅 PRICE TARGET: $1230 POTENTIAL UPSIDE: +122% ✅ ASSUMPTIONS: LTM Revenue: $228.247B 5Y Revenue CAGR: 15% 2031 Profit Margin: 37% 2031 PE Ratio: 26 Shares outstanding: 2.566B Shares reduction: 1%/year VALUATION: Q2 2031 $Meta Platforms, Inc.(META)$ Share Price =228.247 * (1.15)^5 * 0.37 * 26 /[2.566 * (0.99)^5] = 1810$ You can now choose the discount rate that you prefer, for Meta I want to use 10%. ACTUAL PRICE: $555 FAIR VALUE: $1124 1Y PRICE TARGET: $1230 POTENTIAL UPSIDE: +122% EXPECTED RETURNS: 26.7%/year DIVIDEND YIELD: 0.4% Do you own

𝙋𝙊𝙍𝙏𝙁𝙊𝙇𝙄𝙊 𝙐𝙋𝘿𝘼𝙏𝙀 Natan YTD: -19.7% S&P500 YTD: +8.3% TOTAL RETURNS (Jan 2022) Natan's portfolio: +79.2% *Benchmark: +37.3% S&P500: +64.6% MY POSITIONS: 26.8% | $TransMedics Group, Inc.(TMDX)$ 14.5% | $PROCEPT BioRobotics(PRCT)$ 14.2% |$PDD Holdings Inc(PDD)$ 11.8% | $Robinhood(HOOD)$ 11.1% | $Meta Platforms, Inc.(META)$ 6.8% | $Alibaba(BABA)$ 6.1% | $WIZZ AIR(WIZZ.UK)$ 3.8%

Natan YTD: -15.0% S&P500 YTD: +8.9% TOTAL RETURNS (Jan 2022) Natan's portfolio: +89.7% *Benchmark: +40.2% S&P500: +65.5% MY POSITIONS: 26.0% |$TransMedics Group, Inc.(TMDX)$ 15.8% | $PROCEPT BioRobotics(PRCT)$ 13.7% | $PDD Holdings Inc(PDD)$ 11.7% |$Robinhood(HOOD)$ 11.4% | $Meta Platforms, Inc.(META)$ 6.6% | $Alibaba(BABA)$ 6.3% | $Wizz Air Holdings PLC(WZZAF)$ 3.7% |

$Intuitive Surgical(ISRG)$ PRICE IS GETTING ATTRACTIVE 👀 PRICE TARGET: $535 POTENTIAL UPSIDE: +49% ASSUMPTIONS: LTM Revenue: $11.034B 5Y Revenue CAGR: 14% 2031 Profit Margin: 33% 2031 PE Ratio: 38 Shares outstanding: 0.357B Shares reduction: 1%/year VALUATION: Q2 2031 $Intuitive Surgical(ISRG)$ Share Price =11.034 * (1.14)^5 * 0.33 * 38 /[0.357 * (0.99)^5] = 785$ You can now choose the discount rate that you prefer, for Intuitive Surgical I want to use 10%. ACTUAL PRICE: $360 FAIR VALUE: $487 1Y PRICE TARGET: $535 POTENTIAL UPSIDE: +49% EXPECTED RETURNS: 16.9%/year DIVIDEND YIELD: - - - - - - - - - - - - - - - - 𝘛𝘩𝘪𝘴 𝘱𝘰𝘴𝘵 𝘪𝘴 𝘧𝘰𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘢𝘯𝘥 𝘦𝘥𝘶𝘤𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘱𝘶𝘳𝘱𝘰𝘴𝘦𝘴 𝘰𝘯𝘭𝘺.

I decided to sell 100% of my $PayPal(PYPL)$ shares to overexpose my portfolio to $TransMedics Group, Inc.(TMDX)$ and $PROCEPT BioRobotics(PRCT)$ since current valuations make 0 sense to me and businesses are performing well. $PayPal(PYPL)$ has clearly revealed a bad investment even if, at the end, I didn't sold at $40 and I'm down 7% only.

Natan YTD: -14.0% S&P500 YTD: +10.7% TOTAL RETURNS (Jan 2022) Natan's portfolio: +91.6% *Benchmark: +43.0% S&P500: +68.2% MY POSITIONS: 23.1% | $TransMedics Group, Inc.(TMDX)$ 13.9% | $PDD Holdings Inc(PDD)$ 13.1% | $Robinhood(HOOD)$ 12.3% |$PROCEPT BioRobotics(PRCT)$ 11.9% | $Meta Platforms, Inc.(META)$ 6.6% |$Wizz Air Holdings PLC(WZZAF)$ 6.5% | $Alibaba(BABA)$ 5.5% |

$TransMedics Group, Inc.(TMDX)$ IS EXTREMELY UNDERVALUED 😬 PRICE TARGET: $213 POTENTIAL UPSIDE: +216% ✅ ASSUMPTIONS: LTM Revenue: $0.636B 5Y Revenue CAGR: 20% 2031 Profit Margin: 24% 2031 PE Ratio: 40 Shares outstanding: 0.0409B Shares dilution: 2%/year VALUATION: Q1 2031 $TransMedics Group, Inc.(TMDX)$ SHARE PRICE =0.636 * (1.20)^5 * 0.24 * 40 /[0.0409 * (1.02)^5] = 336$ You can now choose the discount rate that you prefer, for Transmedics I want to use 12% ACTUAL PRICE: $68 FAIR VALUE: $191 PRICE TARGET (1Y): $214 POTENTIAL UPSIDE: +214% EXPECTED RETURNS: 37.6%/year DIVIDEND YIELD: - - - - - - - - - - - - - - - - 𝘛𝘩𝘪𝘴 𝘱𝘰𝘴𝘵 𝘪𝘴 𝘧𝘰𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘢𝘯𝘥 𝘦𝘥𝘶𝘤𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘱𝘶𝘳𝘱𝘰𝘴𝘦𝘴 𝘰𝘯𝘭

𝙅𝙐𝙉𝙀 𝟮𝟬𝟮𝟲 𝙋𝙊𝙍𝙏𝙁𝙊𝙇𝙄𝙊 𝙐𝙋𝘿𝘼𝙏𝙀 Natan YTD: -20.2% S&P500 YTD: +10.0% TOTAL RETURNS (Jan 2022) Natan's portfolio: +78.3% *Benchmark: +41.7% S&P500: +67.6% My positions: $TransMedics Group, Inc.(TMDX)$ $PDD Holdings Inc(PDD)$ $PROCEPT BioRobotics(PRCT)$ $Robinhood(HOOD)$ $Meta Platforms, Inc.(META)$ $Wizz Air Holdings PLC(WZZAF)$ $Alibaba(BABA)$

I'm considering buying even more $TransMedics Group, Inc.(TMDX)$. I don't feel like I have enough. A price-to-sales ratio below 4 (not even forward) is far below what the business is really worth, and above all it doesn't remotely reflect the medtech average, where you pay that multiple for mid single-digit growth, while TransMedics is growing at 20%.

Natan YTD: -20.4% S&P500 YTD: +7.4% TOTAL RETURNS (Jan 2022) Natan's portfolio: +77.7% *Benchmark: +35.6% S&P500: +63.2% MY POSITIONS: 22.4% $TransMedics Group, Inc.(TMDX)$ 14.5% | $PROCEPT BioRobotics(PRCT)$ 13.7% | $PDD Holdings Inc(PDD)$ 12.6% | $Robinhood(HOOD)$ 10.7% | $Meta Platforms, Inc.(META)$ 7.4% | $WIZZ AIR(WIZZ.UK)$ 6.0% | $Alibaba(BABA)$ 5.7% |